|
1
|
Kim HY, DeKruyff RH and Umetsu DT: The
many paths to asthma: Phenotype shaped by innate and adaptive
immunity. Nat Immunol. 11:577–584. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Shalaby KH and Martin JG: Overview of
asthma; the place of the T cell. Curr Opin Pharmacol. 10:218–225.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Noelle RJ and Nowak EC: Cellular sources
and immune functions of interleukin-9. Nat Rev Immunol. 10:683–687.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaplan MH: Th9 cells: Differentiation and
disease. Immunol Rev. 252:104–115. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chang HC, Sehra S, Goswami R, Yao W, Yu Q,
Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L, et al: The
transcription factor PU.1 is required for the development of
IL-9-producing T cells and allergic inflammation. Nat Immunol.
11:527–534. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Faulkner H, Renauld JC, Van Snick J and
Grencis RK: Interleukin-9 enhances resistance to the intestinal
nematode Trichuris muris. Infect Immun. 66:3832–3840.
1998.PubMed/NCBI
|
|
7
|
Sehra S, Yao W, Nguyen ET, Glosson-Byers
NL, Akhtar N, Zhou B and Kaplan MH: TH9 cells are required for
tissue mast cell accumulation during allergic inflammation. J
Allergy Clin Immunol. 136:433–440.e1. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Sullivan S, Cormican L, Faul JL,
Ichinohe S, Johnston SL, Burke CM and Poulter LW: Activated,
cytotoxic CD8(+) T lymphocytes contribute to the pathology of
asthma death. Am J Respir Crit Care Med. 164:560–564. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miyahara N, Swanson BJ, Takeda K, Taube C,
Miyahara S, Kodama T, Dakhama A, Ott VL and Gelfand EW: Effector
CD8+ T cells mediate inflammation and airway
hyper-responsiveness. Nat Med. 10:865–869. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Marsland BJ and Le Gros G: CD8+
T cells and immunoregulatory networks in asthma. Springer Semin
Immunopathol. 25:311–323. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Betts RJ and Kemeny DM: CD8+ T
cells in asthma: Friend or foe? Pharmacol Ther. 121:123–131. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Visekruna A, Ritter J, Scholz T, Campos L,
Guralnik A, Poncette L, Raifer H, Hagner S, Garn H, Staudt V, et
al: Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated
airway inflammation. Eur J Immunol. 43:606–618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu Y, Hong B, Li H, Zheng Y, Zhang M, Wang
S, Qian J and Yi Q: Tumor-specific IL-9-producing CD8+
Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for
adoptive immunotherapy of cancers. Proc Natl Acad Sci USA.
111:2265–2270. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Global initiative for asthma, . GINA
report, global strategy for asthma management and prevention.
Available from. http://www.ginasthma.org2015.
|
|
15
|
Bousquet J, Heinzerling L, Bachert C,
Papadopoulos NG, Bousquet PJ, Burney PG, Canonica GW, Carlsen KH,
Cox L, Haahtela T, et al: Practical guide to skin prick tests in
allergy to aeroallergens. Allergy. 67:18–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chung KF, Wenzel SE, Brozek JL, Bush A,
Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, et
al: International ERS/ATS guidelines on definition, evaluation and
treatment of severe asthma. Eur Respir J. 43:343–373. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
ATS/ERS recommendations for standardized
procedures for the online and offline measurement of exhaled lower
respiratory nitric oxide and nasal nitric oxide, 2005, . Am J
Respir Crit Care Med. 2005.171(8): 912–930. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ouyang H, Shi Y, Liu Z, Feng S, Li L, Su
N, Lu Y and Kong S: Increased interleukin-9 and
CD4+IL-9+ T cells in patients with systemic
lupus erythematosus. Mol Med Rep. 7:1031–1037. 2013.PubMed/NCBI
|
|
20
|
Aoudjehane L, Pissaia A Jr, Scatton O,
Podevin P, Massault PP, Chouzenoux S, Soubrane O, Calmus Y and
Conti F: Interleukin-4 induces the activation and collagen
production of cultured human intrahepatic fibroblasts via the
STAT-6 pathway. Lab Invest. 88:973–985. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Gao YD and Yang J: Elevated
interferon regulatory factor 4 levels in patients with allergic
asthma. J Asthma. 49:441–449. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McLane MP, Haczku A, van de Rijn M, Weiss
C, Ferrante V, MacDonald D, Renauld JC, Nicolaides NC, Holroyd KJ
and Levitt RC: Interleukin-9 promotes allergen-induced eosinophilic
inflammation and airway hyperresponsiveness in transgenic mice. Am
J Respir Cell Mol Biol. 19:713–720. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Erpenbeck VJ, Hohlfeld JM, Volkmann B,
Hagenberg A, Geldmacher H, Braun A and Krug N: Segmental allergen
challenge in patients with atopic asthma leads to increased IL-9
expression in bronchoalveolar lavage fluid lymphocytes. J Allergy
Clin Immunol. 111:1319–1327. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huber M and Lohoff M: IRF4 at the
crossroads of effector T-cell fate decision. Eur J Immunol.
44:1886–1895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Louahed J, Toda M, Jen J, Hamid Q, Renauld
JC, Levitt RC and Nicolaides NC: Interleukin-9 upregulates mucus
expression in the airways. Am J Respir Cell Mol Biol. 22:649–656.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
van den Brûle S, Heymans J, Havaux X,
Renauld JC, Lison D, Huaux F and Denis O: Profibrotic effect of
IL-9 overexpression in a model of airway remodeling. Am J Respir
Cell Mol Biol. 37:202–209. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Soroosh P and Doherty TA: Th9 and allergic
disease. Immunology. 127:450–458. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wadsworth S, Sin D and Dorscheid D:
Clinical update on the use of biomarkers of airway inflammation in
the management of asthma. J Asthma Allergy. 4:77–86. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Payne DN, Adcock IM, Wilson NM, Oates T,
Scallan M and Bush A: Relationship between exhaled nitric oxide and
mucosal eosinophilic inflammation in children with difficult
asthma, after treatment with oral prednisolone. Am J Respir Crit
Care Med. 164:1376–1381. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dweik RA, Boggs PB, Erzurum SC, Irvin CG,
Leigh MW, Lundberg JO, Olin AC, Plummer AL and Taylor DR: American
Thoracic Society Committee on Interpretation of Exhaled Nitric
Oxide Levels (FENO) for Clinical Applications: An official ATS
clinical practice guideline: Interpretation of exhaled nitric oxide
levels (FENO) for clinical applications. Am J Respir Crit Care Med.
184:602–615. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Richards DF, Fernandez M, Caulfield J and
Hawrylowicz CM: Glucocorticoids drive human CD8(+) T cell
differentiation towards a phenotype with high IL-10 and reduced
IL-4, IL-5 and IL-13 production. Eur J Immunol. 30:2344–2354. 2000.
View Article : Google Scholar : PubMed/NCBI
|
